Bias from self selection and loss to follow-up in prospective cohort studies.


Journal

European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 20 08 2018
accepted: 07 08 2019
pubmed: 28 8 2019
medline: 16 11 2019
entrez: 28 8 2019
Statut: ppublish

Résumé

Self-selection into prospective cohort studies and loss to follow-up can cause biased exposure-outcome association estimates. Previous investigations illustrated that such biases can be small in large prospective cohort studies. The structural approach to selection bias shows that general statements about bias are not possible for studies that investigate multiple exposures and outcomes, and that inverse probability of participation weighting (IPPW) but not adjustment for participation predictors generally reduces bias from self-selection and loss to follow-up. We propose to substantiate assumptions in structural models of selection bias through calculation of genetic correlations coefficients between participation predictors, outcome, and exposure, and to estimate a lower bound for bias due to self-selection and loss to follow-up by comparing effect estimates from IPP weighted and unweighted analyses. This study used data from the Norwegian Mother and Child Cohort Study and the Medical Birth Registry of Norway. Using the example of risk factors for ADHD, we find that genetic correlations between participation predictors, exposures, and outcome suggest the presence of bias. The comparison of exposure-outcome associations from regressions with and without IPPW revealed meaningful deviations. Assessment of selection bias for entire multi-exposure multi-outcome cohort studies is not possible. Instead, it has to be assessed and controlled on a case-by-case basis.

Identifiants

pubmed: 31451995
doi: 10.1007/s10654-019-00550-1
pii: 10.1007/s10654-019-00550-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

927-938

Références

Stat Methods Med Res. 2013 Jun;22(3):278-95
pubmed: 21220355
Scand J Public Health. 2010 Aug;38(6):648-56
pubmed: 20529967
Epidemiology. 2006 Jul;17(4):413-8
pubmed: 16755269
Eur J Epidemiol. 2017 Jan;32(1):3-20
pubmed: 28220361
Int J Epidemiol. 2006 Oct;35(5):1146-50
pubmed: 16926217
Epidemiology. 2016 Jan;27(1):98-104
pubmed: 26484423
Epidemiology. 2011 Nov;22(6):815-22
pubmed: 21918455
Acta Psychiatr Scand. 2012 Mar;125(3):203-12
pubmed: 22111622
Nat Genet. 2015 Mar;47(3):291-5
pubmed: 25642630
Nat Genet. 2015 Nov;47(11):1236-41
pubmed: 26414676
Epidemiology. 2004 Sep;15(5):615-25
pubmed: 15308962
Am J Epidemiol. 2011 Jan 1;173(1):55-63
pubmed: 21051448
Int J Methods Psychiatr Res. 2007;16(2):52-65
pubmed: 17623385
Acta Psychiatr Scand. 1993 May;87(5):364-7
pubmed: 8517178
Paediatr Perinat Epidemiol. 2009 Nov;23(6):597-608
pubmed: 19840297
Acta Obstet Gynecol Scand. 2000 Jun;79(6):435-9
pubmed: 10857866
Epidemiology. 2013 Jan;24(1):1-9
pubmed: 23211345
Int J Epidemiol. 2010 Apr;39(2):417-20
pubmed: 19926667
Biometrics. 2000 Sep;56(3):779-88
pubmed: 10985216
Int J Epidemiol. 2011 Apr;40(2):345-9
pubmed: 21450688
Hum Genet. 2015 Jul;134(7):803-8
pubmed: 25920518
Int J Epidemiol. 2013 Aug;42(4):1012-4
pubmed: 24062287
J Pharmacokinet Biopharm. 1987 Dec;15(6):657-80
pubmed: 3450848
Int J Epidemiol. 2016 Apr;45(2):382-8
pubmed: 27063603
Acta Obstet Gynecol Scand. 2018 Apr;97(4):407-416
pubmed: 29415329
BMC Med Res Methodol. 2008 Oct 30;8:70
pubmed: 18973665
Drug Alcohol Depend. 2013 Dec 1;133(2):580-6
pubmed: 23972999
Arch Gen Psychiatry. 1993 Nov;50(11):863-70
pubmed: 8215812
Ann Epidemiol. 2007 Sep;17(9):643-53
pubmed: 17553702
J Grad Med Educ. 2012 Sep;4(3):279-82
pubmed: 23997866
Anesth Analg. 2011 Mar;112(3):678-87
pubmed: 21304155
Am J Epidemiol. 1972 Dec;96(6):383-8
pubmed: 4643670
Br J Psychiatry. 2009 Sep;195(3):249-56
pubmed: 19721116
Am J Epidemiol. 2018 Aug 1;187(8):1780-1790
pubmed: 29635276
Biom J. 2009 Feb;51(1):171-84
pubmed: 19197955
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683

Auteurs

Guido Biele (G)

Norwegian Institute of Public Health, Oslo, Norway. guido.biele@fhi.no.

Kristin Gustavson (K)

Norwegian Institute of Public Health, Oslo, Norway.

Nikolai Olavi Czajkowski (NO)

Norwegian Institute of Public Health, Oslo, Norway.

Roy Miodini Nilsen (RM)

Norwegian Institute of Public Health, Oslo, Norway.

Ted Reichborn-Kjennerud (T)

Norwegian Institute of Public Health, Oslo, Norway.

Per Minor Magnus (PM)

Norwegian Institute of Public Health, Oslo, Norway.

Camilla Stoltenberg (C)

Norwegian Institute of Public Health, Oslo, Norway.

Heidi Aase (H)

Norwegian Institute of Public Health, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH